First in Man Study of Safety, Tolerability and PK Profile of RBP-7000
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability and PK profile of a single
dose of 60mg RBO-7000 in stable subjects with schizophrenia who are on medication other than
risperidone.